Iscom (Immuno Stimulating Complex)-vaccine of equine influenza virus transmission electron microscopical investigation and literature review;Iscom (Immuno Stimulating Complex)-vakzine des equinen influenza-virus - Transmissionselektronenmikroskopische chargenüberwachung und literaturübersicht

Deutsche Tierarztliche Wochenschrift

Volumn 104, Issue 6, 1997, Pages 196-202

  Brugmann M ^a,c   Drommer, W ^a   Reichl, U ^b   Boge, A ^b  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b Mallinckrodt Veterinary GmbH   (Germany)

^c Institut fur Pathologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; ISCOM;

ANIMAL; ANIMAL DISEASE; ELECTRON MICROSCOPY; HORSE; HORSE DISEASE; HUMAN; IMMUNOLOGY; INFLUENZA; ORTHOMYXOVIRUS; REVIEW; ULTRASTRUCTURE;

ANIMALS; HORSE DISEASES; HORSES; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; ISCOMS; MICROSCOPY, ELECTRON; ORTHOMYXOVIRIDAE;

EID: 0031160738     PISSN: 03416593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. AKERBLOM, L., K. STRÖMSTEDT, S. HÖGLUND, A.D.E. OSTERHAUS und B. MOREIN (1989): Formation and characterization of FeLV Iscoms. Vaccine 7, 142-146.
2. AKERBLOM, L., P. NARA, N. DUNLOP, S. PUTNEY und B. MOREIN (1993): HIV experimental vaccines based on the iscom technology using envelope and GAG gene products. Biotechnol. Ther. 4 (3-4), 145-161.
3. AKAHASHI, H., T. TAKESHITA, B. MOREIN, S. PUTNEY, R.N. GERMAIN und J.A. BERZOFSKY (1990): Induction of CD8+ cytotoxic T-cells by immunization with purified HIV-1-envelope protein in Iscoms. Nature 344, 873-879.
4. ARAUJO, F.G. und B. MOREIN (1991): Immunization with Trypanosoma cruzi epimastigote antigens incorporated into Iscoms protects against lethal challenge in mice. Infect Immunol. 59, 209-215.
5. BARR, I.G. und G.F. MITCHELL (1996): Iscoms (immunostimulating complexes): The first decade. Immunol. Cell Biol. 74, 8-25.
6. BERGSTROM-MOLLAOGLU, M., K. LÖVGREN, L. AKERBLOM, C. FOSSUM und B. MOREIN (1992): Antigen-specific increases in the number of splenocytes expressing MHC class II molecules following restimulation with antigen in various physical forms. Scand. J. Immunol. 36, 565-574.
7. BUXTON, D., A. UGGLA, K. LÖVGREN, K. THOMSON, A. LUNDEN, B. MOREIN und D.A. BLEWETT (1989): Trial of a novel experimental Toxoplasma Iscom vaccine in pregnant sheep. Br. Vet. J. 145(5), 451-457.
8. CHARLES, S.D., I. HUSSAIN, C.U. CHOI, K.J. NAGARAJA und V. SIVANANDAN (1994): Adjuvanted subunit vaccines for the control of Salmonella enteritidis infection in turkeys. Am. J. Vet. Res. 55(5), 636-642.
9. DALSGAARD, K. (1978): A study of the isolation and characterization of the saponine Quil A. Acta Vet. Scand. Suppl. 69, 1-12.
10. DALSGAARD, K. (1984): Assessment of the dose of the immunological adjuvant Quil A in mice and guinea pigs using sheep red blood cells as model antigen. Zbl. Vet. Med. B 31, 718-720.
11. DEVRIES, P., R.S. VAN BINNENDIJK, P. VAN DER MAREL, A.L. VAN WEZEL, H.O. VOORMA, B. SUNDQUIST, F.G. UYTDEHAAG und A.D.E. OSTERHAUS (1988a): Measles virus fusion protein presented in an immune-stimulating complex (Iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice. J. Gen. Virol. 69, 549-559.
12. DE-VRIES, P., F.G. UYTDEHAAG und A.D.E. OSTERHAUS (1988b): Canine distemper virus (CDV) immune-stimulating complexes (Iscoms), but not measles virus iscoms, protect dogs against CDV infection. J. Gen. Virol. 69, 2071-2083.
13. ERTURK, M., R. JENNINGS, D. HOCKLEY und C.W. POTTER (1989): Antibody responses and protection in mice immunized with herpes simplex virus type 1 antigen immune-stimulating complex preparations. J. Gen. Virol. 70, 2149-2155.
14. FEKADU, M., J.H. SHADDOK, J. EKSTROM, A. OSTERHAUS, D.W. SANDERLIN, B. SUNDQUIST und B. MOREIN (1992): An immune stimulating complex (Iscom) subunit rabies vaccine protects dogs and mice against street rabies challenge. Vaccine 10, 192-197.
15. FOHLMAN, J., K. PAUKSEN, B. MOREIN, U. BJARE, N.G. ILBACK und G. FRIMAN (1993): High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis. Scand J. Infect. Dis. Suppl. 88, 103-108.
16. GOLOVLIOV, I., M. ERICSSON, L. AKERBLOM, G. SANDSTROM, A. TARNIVIK und A. SJÖSTEDT (1995): Aduvanticity of iscoms incorporating a T-cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis. Vaccine 13, 261-267.
17. HANNANT, D., D.M. JESSETT, T. O'NEILL, C.A. DOLBY, R.F. COOK und J.A. MUMFORD (1993): Responses of ponies to equid herpesvirus-1 iscom vaccination and challenge with virus of the homologous strain. Res. Vet. Sci. 54(3), 299-305.
18. HÖGLUND, S., K. DALSGAARD, K. LÖVGREN, B. SUNDQUIST, A.D.E. OSTERHAUS und B. MOREIN (1989): Iscoms and immunostimulation with viral antigens. In: Subcellular Biochemistry, Vol. 15 (Ed. J.R. HARRIS) Plenum Press, New York, 39-86.
19. JACKSON, L.A. und J.P. OPDEBEECK (1994): Quil A and Iscom as adjuvants for midgut membrane antigens of Boophilus microplus. App. Parasitol. 35, 87-98.
20. KAHN, S.N., N.L. STANTON, A.J. SUMNER, M.J. BROWN, S.L. SPITALNlK und B. MOREIN (1989): Analysis of the feline immune response to human myelin-associated glycoprotein. J. Neurol. Sci. 89, 141-148.
21. KAMSTRUP, S., L. RONSHOLT, M.H. JENSEN und K. DALSGAARD (1992): A novel subunit iscom vaccine against bovine virus diarrhoea virus. Rev. Sci. Tech. 11, 873-877.
22. KERSTEN, G.F., A. SPIEKSTRA, E.C. BEUVERY und D.J. CROMMELIN (1991): On the structure of immune-stimulating saponin-lipid complex (Iscoms). Biochem.Biophys.-Acta 1062(2), 165-171.
23. KERSTEN, G.F., T. TEERLINK, H.J. DERKS, A.J. VERKLEIJ, T.L. VAN WEZEL, D.J. CROMMELIN und E.C. BEUVERY (1988): Incorporation of the major outer membrane protein of Neisseria gonorrhoeae in saponin-lipid complexes (Iscoms): chemical analysis, some structural features, and comparison of their immunogenicity with three other antigen delivery systems. Infect. Immunol. 56(2), 432-438.
24. LARSSON, M., K. LÖVGREN und B. MOREIN (1993): Immunopotentiation of synthetic oligopeptides by chemical conjugation to iscoms. J. Immunol. Methods 162, 257-260.
25. LIPFORD, G.B., H. WAGNER und K. HEEG (1994): Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells. Vaccine 12(1), 73-80.
26. LÖVGREN, K. (1988): The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes. Scand J. Immunol. 27, 241.
27. MERZA, M., S. BELAK und B. MOREIN (1988): Charakterization of an iscom prepared with envelope glycoproteins of bovine herpesvirus typ1. Zentralbl. Veterinärmed. B 35, 695-703.
28. MERZA, M.S., T. LINNE, S. HÖGLUND, D. PORTETELLE, A. BURNY und B. MOREIN (1989): Bovine leukaemia virus Iscoms: biochemical characterization. Vaccine 7(1), 22-28.
29. MOREIN, B., M. SHARP, B. SUNDQUIST und K. SIMONS (1983): Protein subunit vaccines of parainfluenza type 3 virus: immunogenic effect in lambs and mice. J. Gen. Virol. 64, 1557-1563.
30. MOREIN, B., B. SUNDQUIST, S. HÖGLUND, K. DALSGAARD und A.D.M.E. OSTERHAUS (1984): Iscom, a novel structure for antigenetic presentation of membrane proteins from enveloped viruses. Nature 308, 457.
31. MOREIN, B. und K. SIMONS (1985): Subunit vaccines against enveloped viruses: virosomes, micelles and other protein complexes. Vaccine 3, 83-89.
32. MOREIN, B., K. LÖVGREN, S. HÖGLUND und B. SUNDQUIST (1987a): The Iscom, an immunostimulating complex, Immunol. Today 8, 333-338.
33. MOREIN, B. (1987b): Potentiation of the immune response by immunization with antigens in defined multimeric physical forms. Vet. Immunol. Immunopathol. 17, 153-159.
34. MOREIN, B. (1987c): Iscom - an immunostimulating complex. Arzneim. Forsch./Drug Res. 37, 1418.
35. MOREIN, B. (1988): The Iscom antigen-presenting system. Nature 332, 287-288.
36. MOREIN, B., S. BELAK, T. SOOS, M. RUSVAI, B.S. MCGWIRE und K. BOGNAR (1989): Iscom of viral proteins against Aujeszky's disease. Vet. Microbiol. 20(2), 143-154.
37. WOREIN, B. (1990): Iscoms. Vet. Microbiol. 23, 79-84.
38. MOREIN, B., K. LÖVGREN, B. RÖNNBERG, A. SJÖLANDER und M. VILLACRES-ERIKSSON (1995): Immunostimulating complexes. Clinical potential in vaccine development. Clin. Immunother. 3(6), 461-475.
39. MORGAN, A.J., S. FINERTY, K. LÖVGREN, F.T. SCULLION und B. MOREIN (1988): Prevention of Eppstein-Barr (EB) virus-induced lymphoma in cottontop Tamarins by vaccination with the EB virus envelope glycoprotein gp340 incorporated into immune-stimulating complexes. J. Gen. Virol. 69, 2093-2096.
40. MOWAT, A.W., A.M. DONACHIE, G. REID und O. JARRETT (1991): Induction of class I-MHC-restricted T-cells and stimulation of mucosal immunity by incorporation of soluble protein in Iscoms. Lymphoid Cells and Molecules in Infection Immunity Elsinore, Denmark, 17-21 May 1991, Statens Seruminstitut, 33.
41. - MUMFORD, J.A., D. JESSETT, U. DUNLEAVY, J. WOOD, D. HANNANT, B. SUNDQUIST und R.F. COOK (1994): Antigenicity and immunogenicity of experimental equine influenza Iscom vaccines. Vaccine 12, 857-863.
42. OSTERHAUS, A.D.E., K. WEIJER, F.G. UYTDEHAAG, P. KNELL, O. JARRETT, L. AKERBLOM und B. MOREIN (1989): Serological responses in cats vaccinated with FeLV Iscom and an inactivated FeLV vaccine. Vaccine 7(2), 137-141.
43. OSTERHAUS, A.D.E. und P. DE VRIES (1992a): Vaccination against acute respiratory virus infectionsand measles in man. Immunobiol. 184, 180-192.
44. OSTERHAUS, A.D.E., P. DE VRIES, B. MOREIN, L. AKERBLOM und J. HEENEY (1992b): SIV-specific protective immunity in macaques vaccinated with SIV-iscom or MDP adjuvanted whole inactivated SIV. Aids Res. Human Retroviruses 8, 1507-1510.
45. ÖZEL, M., S. HOGLUND, H.R. GELDERBLOM und B. MOREIN (1989): Quaternary structure of the immunostimulating complex (Iscom). J. Ultrastruct. Mol. Struct. Res. 102, 240-248.
46. PUTKONEN, P., E. BJORLING, L. AKERBLOM, R. THORSTENSSON K. LÖVGREN, L. BENTHIN, E. CHIODI, B. MOREIN, B. BIBERFELD und E. NORBY (1994): Long standing protection of macaques against cell-free HIV-2 with HIV-2 iscom vaccine. J. Acquir. Immune Defic. Syndr. 7(6), 551-559.
47. PYLE, S.W., B. MOREIN, J.W. BESS JR., L. AKERBLOM, P.L. NARA, S.M. NIGIDA JR., N.W. LERCHE, P.J. FISCHINGER und L.O. ARTHUR (1989): Immune response to immunostimulating complexes (Iscoms) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120). Vaccine 7, 465-473.
48. RIMMELZWAAN, G.F., H.J. SIEBELINK, C. HUISMAN, B. MOSS, M.J. FRANCIS und A.D.E. OSTERHAUS (1994): Removal of the cleavage site of recombinant feline immunodeficiency virus envelope protein facilitates incorporation of surface glycoprotein in immune stimulating complexes. J. Gen. Virol. 75, 2097-2102.
49. ROBINSON, D.G., U. EHLERS, R. HERKEN, B. HERRMANN, F. MAYER und F.-W. SCHÜRMANN (1985): Präparationsmethodik in der Elektronenmikroskopie. Springer-Verlag Berlin, Heidelberg, New York, Tokio, 72-76.
50. ROBINSON, K., T. BELLABY und D. WAKELIN (1994): Vaccination against the nematode Trichinella spiralis in high and low responder mice. Effects of different adjuvants. Protective immunity and immune response. Immunol. 82, 261-267.
51. ROLLE, M und A. MAYR (1993): Medizinische Mikrobiologie, Infektions- und Seuchenlehre. Ferdinand Enke-Vertag, 396-399.
52. SJÖLANDER, A., S. STAHL und K. LÖVGREN (1994): Plasmodium falciparum: The immune response in rabbits to the clustered-arginine-rich-protein (CARP) after immunization in Freund's adjuvant or immunostimulating complexes (ISCOMS). Exp. Parasitol. 76, 134-145.
53. SPEIJERS, G.J., L.H. DANSE, E.C. BEUVERY, J.J. STRIK und J.G. VOS (1988): Local reactions of the saponin Quil A and a Quil A containing iscom measles vaccine after intramuscular injection of rats: a comparison with the effect of DPT-polio vaccine. Fundam. Appl. Toxicol. 10(3), 425-430.
54. SUNDQUIST, B., K. LÖVGREN, S. HOGLUND und B. MOREIN (1988a): Influenza virus Iscoms: biochemical characterization. Vaccine 6(1), 44-48.
55. SUNDQUIST, B., K. LÖVGREN und B. MOREIN (1988b): Influenza virus Iscoms: antibody response in animals. Vaccine 6, 49-53.
56. TAKAHASHI, H., T. TAKESHITA, B. MOREIN, S. PUTNEY, R.N. GERMAIN und J.A. BERZOFSKY (1990): Induction of CD8+ cytotoxio T cells by immunization with purified HIV-1 envelope protein in Iscoms. Nature 344, 873-875.
57. TRUDEL, M., G. BOULAY, C. SEGUIN, F. NADON und G. LUSSIER (1988): Control of infectious bovine rhinotracheitis in calves with a BHV-1 subunit-Iscom vaccine. Vaccine 6(6), 525-529.
58. TRUDEL, M., F. NADON, C. SEQUIN, C. SIMAND und G. LUSSIER (1989): Experimental polyvalent Iscom's subunit vaccine induces antibodies that neutralize human and bovine respiratory syncytial virus. Vaccine 7, 12-16.
59. UGGLA, A., F.G. ARAUJO, A. LUNDEN, K. LÖVGREN, J.S. REMINGTON und B. MOREIN (1988): Immunizing effects in mice of two Toxoplasma gondii Iscom preparations. Zentralbl. Veterinärmed. B 35(4), 311-314.
60. VILLACRES-ERIKSSON, M., M. BERGSTROM-MOLLAOGLU, H. KABERG, K. LOVGREN und B. MOREIN (1993): The induction of cell-associated and secreted IL-1 by iscoms, matrix or micelles in murine splenic cells. Clin. Exp. Immunol. 93, 120-125.
61. VISSER, I.K., M.W. VAN DE BILDT, H.N. BRUGGE, P.J. REIJNDERS, E.J. VEDDER, J. KUIPER, P. DE-VRIES, J. GROEN, H.C. WALVOORT und F.G. UYTDEHAAG (1989): Vaccination of harbour seals (Phoca vitulina) against phocid distemper with two different inactivated canine distemper virus (CDV) vaccines. Vaccine 7(6), 521-526.
62. WATSON, D.L., N.A. WATSON, C. FOSSUM, K. LÖVGREN und B. MOREIN (1992): Interactions between immune-stimulating complexes (Iscoms) and peritoneal mononuclear leucocytes. Microbiol. Immunol. 36, 199-203.
63. WEIJER, K., F.G. UYTDEHAAG und A.D.E. OSTERHAUS (1989): Control of feline leukaemia virus. Vet. Immunol. Immunopathol. 21, 69-83.